Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
10/2007
10/17/2007EP1141728B1 Kidney disease detection and treatment
10/17/2007CN101054414A Method of extracting and preparing deer DGF
10/17/2007CN100342912C Sustained release composition for oral administration of drugs
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007113540A2 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle
10/11/2007WO2007088050A3 Method of treatment for muscular dystrophy
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238768 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238766 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007US20070238711 Combination Therapy with Glatiramer Acetate and Minocycline for the Treatment of Multiple Sclerosis
10/11/2007US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007US20070238171 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
10/11/2007DE202007009679U1 Zusammensetzungen und Verwendungen davon zur Behandlung von Muskelschwundzuständen Compositions and uses thereof for the treatment of muscle wasting conditions
10/11/2007DE19701619B4 Verwendung von Pramipexol zur Behandlung des restless legs syndroms Use of pramipexole in the treatment of restless legs syndrome
10/11/2007CA2648351A1 Regulating fat and carbohydrate oxidation in muscle tissue
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842539A1 Use of N- (dibenz(b,f)oxepin-10-ylmethyl)N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency
10/10/2007EP1841788A1 Novel snake toxin
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP0967892B2 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
10/10/2007CN101049316A Application of medical use lithium salt or medical use medication of valproic acid class as medication for treating sclerosis of amyotrophia
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279496 suitable for the prophylaxis or treatment of psychoses, schizophrenia, depression, anxiety states, dementia, in particular Alzheimer's disease and Lewy bodies dementia, neurodegenerative disorders, etc.
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/09/2007US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide
10/04/2007WO2007110977A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
10/04/2007US20070232658 Protein Kinase C Inhibitors for the Treatment of Autoimmune Diseases and of Transplant Rejiction
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070231309 Cell populations which co-express CD49c and CD90
10/03/2007EP1840208A1 Method of inducing differentiation of skeletal muscle cell
10/03/2007EP1839674A1 CD40 antagonist for treating psoriasis
10/03/2007EP1351968B1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/03/2007EP1351744B1 Use of specific erbb4 antagonists for treating stenosis
10/03/2007EP1306093B1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
10/03/2007EP1042307B1 Aminothiazole inhibitors of cyclin dependent kinases
10/03/2007CN101048166A Abnormal protein removing composition
10/03/2007CN100340561C Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/02/2007US7276593 Proteins and nucleic acids encoding same
10/02/2007US7276580 Neurotrophic factors
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007CA2401229C Aryl fused azapolycyclic compounds
10/02/2007CA2378613C Selective iglur5 receptor antagonists for the treatment of migraine
09/2007
09/27/2007WO2007108530A1 Muscle fatigue remedy
09/27/2007WO2007108434A1 Expression construct for digesting aggregating protein and method of inhibiting the aggregation of aggregating protein
09/27/2007WO2007049088A8 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues
09/27/2007US20070225300 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
09/27/2007US20070225237 Methods for the prevention and/or the treatment of glutamate cytotoxicity
09/27/2007US20070225236 Methods for the prevention and/or the treatment of glutamate cytotoxicity
09/27/2007US20070225235 Methods for the prevention and/or the treatment of glutamate cytotoxicity
09/27/2007US20070225214 Use of osteopontin for the treatment and/or prevention of neurologic diseases
09/27/2007US20070224265 Tablet Comprising Branched Chain Amino Acid and Method for Producing the Same
09/27/2007US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists
09/27/2007US20070224221 Botulinum toxin neurotoxic component for treating juvenile cerebral palsy
09/27/2007US20070224168 Isolated Muscle Satellite Cells, Use Thereof in Muscle Tissue Repair and Method for Isolating Said Muscle Satellite Cells
09/26/2007EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
09/26/2007EP1836197A1 Selective muscle relaxant and pharmaceutical compositions
09/26/2007EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
09/26/2007EP1458708B1 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
09/26/2007EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
09/26/2007EP1383750B1 Urea derivatives as integrin alpha 4 antagonists
09/26/2007EP1228367B1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
09/26/2007CN101041626A Tetrafluorobenzyl derivatives and pharmaceutical composition containing same
09/26/2007CN101040867A Application of fucoidan in the preparation of medicine and health-care products for preventing and treating neurodegenerative diseases
09/26/2007CN100339356C Aminoadamantane derivatives as therapeutic agents
09/26/2007CN100339080C Antiviral compounds
09/26/2007CN100339072C Methocarbamol dry mixing suspension
09/25/2007US7273964 Non-human transgenic animals for the study of neurodegenerative syndromes
09/25/2007US7273888 Administrating inhibitors of ornithine decarboxylase (involved with synthesis of putrescine; antiproliferative agents
09/25/2007US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator
09/20/2007WO2007088123A3 Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
09/20/2007WO2007055804A3 Methods and compositions for administration of iron for the treatment of restless leg syndrome
09/20/2007WO2006130687A3 Liver/plasma concentration ratio for dosing hepatitis c virus protease inhibitor
09/20/2007US20070219255 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
09/20/2007US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both
09/20/2007US20070219180 Muscle Relaxtion Accelerator and Therapeutic Agent for Muscular Tissue Diseases Such as Muscle Relaxation Failure
09/20/2007US20070218037 Therapeutic agent for fibromyalgia
09/20/2007DE4003844B4 Neue Cyclosporin enthaltende galenische Formulierungen New cyclosporin-containing pharmaceutical formulations
09/20/2007CA2646316A1 Methods of treating muscular wasting diseases using nf-kb activation inhibitors
09/19/2007EP1834959A2 Tert-butyl-substituted aromatic steroids having cytoprotective activity
09/19/2007EP1833847A2 Methods of treating obesity with combination therapeautics of igf-1 fusion polypeptides
09/19/2007EP1439841B1 Androgen receptor modulators and methods of use thereof
09/19/2007EP1406605B1 Carbamates of 2-heterocyclic-1,2-ethanediols
09/19/2007EP1192134B1 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 233